| 引用本文: |
张海军,董璠玙,袁妮.分布成本-效果分析方法介绍及案例分析[J].中国卫生经济,2023,42(1):4-8.[点击复制] |
ZHANG Hai-jun,DONG Fan-yu,YUAN Ni.Introduction to Distributional Cost-Effectiveness Analysis and Case Study[J].CHINESE HEALTH ECONOMICS,2023,42(1):4-8.[点击复制] |
|
| 摘要: |
| 目的：系统梳理分布成本-效果分析的方法及应用，为将来中国药物经济学评价提供新思路。方法：通过检索、 筛选，对分布成本-效果分析的方法流程进行梳理和介绍。结果：对应用案例分析后发现，很多卫生干预措施无法做到同时兼顾健康收益和健康公平，某些实现健康收益最大化的干预措施恰恰是在健康公平方面收益最小的措施，甚至会导致更严重的健康不平等。结论：分布成本-效果分析是一种可以为决策者提供健康收益最大化和最大程度实现健康公平信息的全新方法， 在我国有较大的应用价值，准确而全面地收集高质量数据是分布成本-效果分析面临的最大挑战。 |
| 关键词: 药物经济学评价 成本-效果分析 分布成本-效果分析 健康不平等 |
| DOI： |
|
| 基金项目: |
|
| Introduction to Distributional Cost-Effectiveness Analysis and Case Study |
| ZHANG Hai-jun,DONG Fan-yu,YUAN Ni |
| () |
| Abstract: |
| Objective: To systematically review the methods and case applications of distributed cost-effectiveness Analysis and provide new ideas for the evaluation of pharmacoeconomic in China in the future. Methods: By retrieving，screening，and analyzing the research guidelines and key application cases related to the analysis of distributed cost effects，while the DCEA methods and processes are sorted out and introduced. Results: It includes a DCEA use case of colorectal cancer screening measures conducted by the United Kingdom and South Korea. It is found that many health interventions fail to balance health benefits and health equity at the same time，and some interventions that maximize health benefits are precisely the measures that benefit the least in terms of health equity，and even lead to more serious health inequities. Conclusion: With great application value in China，DCEA is a new method that can provide decision-makers with information on maximizing health benefits and achieving health equity to the greatest extent. However，accurate and comprehensive high-quality data collection is the biggest challenge for DCEA. |
| Key words: pharmacoeconomic evaluation cost-effectiveness analysis distributional cost-effectiveness analysis health inequality |
